- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Generic Drugs
Teva Pharmaceutical Industries Ltd
Add to PortfolioTEVA:US
38.1000 USD 0.5100 1.32%As of 20:10:00 ET on 05/29/2012.
Snapshot for Teva Pharmaceutical Industries Ltd (TEVA)
| Open: | 38.6100 | Day's Range: | 38.1000 - 38.8000 | Volume: | 29,462,746 | Bid: | 38.1000 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 38.6100 | 52wk Range: | 35.0000 - 51.1500 | 1-Yr Rtn: | -22.76% | Ask: | 38.1100 |
Key Statistics for TEVA
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | 7.0256 |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2012) | 5.4230 |
| Est. PEG Ratio | 0.8683 |
| Market Cap (M USD) | 35,920.84 |
| Shares Outstanding (M) | 942.80 |
| Enterprise Value (M USD) (ttm) | - |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 2.7440 |
| Next Earnings Announcement | 07/26/2012 |
More TEVA Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for TEVA
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for TEVA
Teva Pharmaceutical Industries Ltd., is a global pharmaceutical company. The Company develops, manufactures, and markets generic and branded human pharmaceuticals as well as active pharmaceutical ingredients.
| Phillip FrostChairman | Moshe ManyVice Chairman |
| Jeremy M LevinPresident/CEO | Eyal DeshehChief Financial Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page